Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 32 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2014Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?Wu, T.; Thazhath, S.; Bound, M.; Jones, K.; Horowitz, M.; Rayner, C.
2017Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Horowitz, M.; Jones, K.; Rayner, C.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2017Effects of vildagliptin and metformin on blood pressure and heart rate responses to small intestinal glucose in type 2 diabetes.Wu, T.; Trahair, L.; Little, T.; Bound, M.; Zhang, X.; Wu, H.; Sun, Z.; Horowitz, M.; Rayner, C.; Jones, K.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2017Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy malesWu, T.; Rayner, C.; Watson, L.; Jones, K.; Horowitz, M.; Little, T.
2017Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetesWu, T.; Xie, C.; Wu, H.; Jones, K.; Horowitz, M.; Rayner, C.
2017Blockade of glucagon-like peptide-1 receptors by exendin(9-39) attenuates the increase in heart rate during small intestinal glucose infusion in type 2 diabetesRayner, C.; Wu, T.; Horowitz, M.; Jones, K.; 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017) (11 Sep 2017 - 15 Sep 2017 : Lisbon, PORTUGAL)
2017Endogenous glucagon-like peptide-1 mediates the lowering of glycaemia during small intestinal glucose infusion by bile acids in type 2 diabetesWu, T.; Horowitz, M.; Jones, K.; Rayner, C.; 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017) (11 Sep 2017 - 15 Sep 2017 : Lisbon, PORTUGAL)